US Stock MarketDetailed Quotes

INKT MiNK Therapeutics

Watchlist
  • 0.790
  • -0.020-2.47%
Close Aug 9 16:00 ET
  • 0.830
  • +0.040+5.00%
Post 20:02 ET
27.43MMarket Cap-1338P/E (TTM)

MiNK Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MiNK Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 13, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.09

+50.03%
Analyst Rating

Buy

Jul 31, 2024

MiNK Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
Aug 13, 20242024/Q2-- / 0.000--
May 14, 20242024/Q10.000 / 0.000--
Mar 21, 20242023/Q40.000 / 0.000--
Nov 9, 20232023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
Aug 13, 20242024/Q2-- / 0.000--
May 14, 20242024/Q10.000 / 0.000--
Mar 21, 20242023/Q40.000 / 0.000--
Nov 9, 20232023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

MiNK Therapeutics Earnings Reports

  • MiNK Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 14 07:29 ET

  • MiNK Therapeutics | 10-K: FY2023 Annual Report

    Mar 21 16:07 ET

  • MiNK Therapeutics: Q3 2023 Earnings Report

    Nov 14, 2023 17:17 ET

  • MiNK Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 07:26 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg